Perceptive Advisors - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2020$28,819,000
+35.2%
329,8900.0%0.42%
+22.0%
Q2 2020$21,308,000
+38.0%
329,890
-5.7%
0.34%
-14.2%
Q1 2020$15,441,000
-43.3%
349,890
-20.0%
0.40%
-25.7%
Q4 2019$27,245,000
+21.3%
437,390
-26.8%
0.54%
-10.6%
Q3 2019$22,454,000
+29.8%
597,190
+40.5%
0.60%
+52.4%
Q2 2019$17,296,000424,9680.40%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders